These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 1659789)

  • 21. Low-molecular-weight heparin (LMWH) in the treatment of thrombosis.
    Holzheimer RG
    Eur J Med Res; 2004 Apr; 9(4):225-39. PubMed ID: 15210403
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention of deep venous thrombosis by a new low molecular weight heparin (Fluxum) in cardiac surgery.
    Beghi C; Fragnito C; Antonelli A; Reverberi C; Ferrari P; Saccani S; Fesani F
    Int Angiol; 1993 Dec; 12(4):383-6. PubMed ID: 8207317
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Subcutaneous low-molecular-weight heparin compared with continuous intravenous unfractionated heparin in the treatment of proximal deep vein thrombosis.
    Simonneau G; Charbonnier B; Decousus H; Planchon B; Ninet J; Sie P; Silsiguen M; Combe S
    Arch Intern Med; 1993 Jul; 153(13):1541-6. PubMed ID: 8391792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blood coagulation and thrombosis in patients with ovarian malignancy.
    von Tempelhoff GF; Dietrich M; Niemann F; Schneider D; Hommel G; Heilmann L
    Thromb Haemost; 1997 Mar; 77(3):456-61. PubMed ID: 9065993
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Role of low molecular weight heparin in the prevention of postoperative deep venous thrombosis. Our experience in 88 cases].
    Verardi S; Cortese F; Baroni B; Boffo V; Casciani CU
    G Chir; 1989 Nov; 10(11):674-8. PubMed ID: 2562010
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Therapeutic indications of low molecular weight heparins].
    Samama MM; Michaut-Paterno F
    Arch Mal Coeur Vaiss; 1991 Nov; 84(11 Suppl):1733-43. PubMed ID: 1662941
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low molecular weight heparin (Alfa LHWH) compared with unfractionated heparin in prevention of deep-vein thrombosis after hip fractures.
    Pini M; Tagliaferri A; Manotti C; Lasagni F; Rinaldi E; Dettori AG
    Int Angiol; 1989; 8(3):134-9. PubMed ID: 2556484
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Evaluation of the effectiveness and safety of Fragmin (Kabi 2165) versus calcium heparin in the prevention of deep venous thrombosis in general surgery].
    Creperio G; Marabini M; Ciocia G; Bergonzi M; Fincato M
    Minerva Chir; 1990 Sep; 45(17):1101-6. PubMed ID: 2177861
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low molecular weight heparin for the prevention of venous thromboembolism after abdominal surgery.
    Bergqvist D
    Br J Surg; 2004 Aug; 91(8):965-74. PubMed ID: 15286956
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low molecular weight heparin compared with unfractionated heparin in prevention of postoperative thrombosis.
    Samama M; Bernard P; Bonnardot JP; Combe-Tamzali S; Lanson Y; Tissot E
    Br J Surg; 1988 Feb; 75(2):128-31. PubMed ID: 2832030
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of low-molecular-weight heparins in the prevention of venous thrombosis in surgery with special reference to enoxaparin.
    Haas S
    Haemostasis; 1996; 26 Suppl 2():39-48. PubMed ID: 8707166
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enoxaparin. A review of its pharmacology and clinical applications in the prevention and treatment of thromboembolic disorders.
    Buckley MM; Sorkin EM
    Drugs; 1992 Sep; 44(3):465-97. PubMed ID: 1382939
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Controlled clinical study of the efficacy of a new low molecular weight heparin administered subcutaneously to prevent post-operative deep venous thrombosis.
    Valle I; Sola G; Origone A
    Curr Med Res Opin; 1988; 11(2):80-6. PubMed ID: 2851413
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Efficacy and tolerance of Fraxiparine in the prevention of deep vein thrombosis in general surgery performed with medullar conduction anesthesia].
    Eurin B
    Ann Fr Anesth Reanim; 1994; 13(3):311-7. PubMed ID: 7992938
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Peri- and postoperative use of low molecular weight heparin in peripheral vascular surgery].
    Samama CM; Mouren S; Bridel MP; Combe S; Koskas F; Kieffer E; Viars P
    Ann Fr Anesth Reanim; 1990; 9(2):102-5. PubMed ID: 2163591
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low molecular weight heparins and their use in obstetrics and gynecology.
    Fejgin MD; Lourwood DL
    Obstet Gynecol Surv; 1994 Jun; 49(6):424-31. PubMed ID: 8090379
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention of thrombotic complications of the nephrotic syndrome by the low-molecular-weight heparin enoxaparin.
    Rostoker G; Durand-Zaleski I; Petit-Phar M; Ben Maadi A; Jazaerli N; Radier C; Rahmouni A; Mathieu D; Vasile N; Rosso J
    Nephron; 1995; 69(1):20-8. PubMed ID: 7891793
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Prevention of thrombosis among medical inpatients : should we adapt enoxaparin doses to the patient's weight ?].
    Tognon M; Darbellay Farhoumand P; Blondon M; Agoritsas T
    Rev Med Suisse; 2017 Oct; 13(579):1788-1791. PubMed ID: 29064195
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enoxaparin prophylaxis for deep vein thrombosis in orthopaedic surgery.
    Grey A; Horne G; Carter J
    N Z Med J; 1992 Mar; 105(930):104-5. PubMed ID: 1313165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.